Provider review · 68/100

Sequence (WW Clinic) review

68/100. Program + insurance semaglutide, Program + insurance tirzepatide.

Score 68/100Sema Program + insuranceTirz Program + insurance

Sequence is the clinical arm of WW (formerly Weight Watchers). Low program fee with insurance-routed medication. Similar model to Calibrate. We rank them #10 at 68/100.

Sequence (WW Clinic) in one line: Editorial score 68/100. Semaglutide Program + insurance, tirzepatide Program + insurance.

Score breakdown — 68/100

CriterionMaxSequence (WW Clinic)Notes
1. Pricing transparency2516Program fee transparent; total cost insurance-dependent.
2. Pharmacy sourcing2012Insurance routing — varies.
3. Clinical oversight1512Functional clinical model.
4. Regulatory clarity1513Standard for insurance-routed model.
5. Patient experience1511WW app integration; coaching layer.
6. Evidence quality104Outcome reporting thin.
Total10068Rubric application as of May 20, 2026.

Strengths

Weaknesses

Who should pick Sequence (WW Clinic)

Who should look elsewhere

How Sequence (WW Clinic) compares with our #1 pick

NexLife outscores Sequence (WW Clinic) on our published rubric. The reasons are summarized in our direct comparison: All comparisons. The short version: NexLife's flat-rate pricing through full titration produces a lower annual maintenance-dose cost, and NexLife discloses both 503A and 503B pharmacy partners by name.

Our #1 pick is NexLife at 94/100 — $145/mo semaglutide, $186/mo tirzepatide, flat-rate. See full NexLife review →

Frequently asked

Sequence vs Calibrate?

Similar model. Sequence's program fee is lower ($99 vs $138); Calibrate's coaching curriculum is more structured.

Need to be a WW member?

No, Sequence is open to non-WW members but app integration favors WW users.

JB
Dr. J. Bottoni, M.D. Chief Medical Advisor · View bio →
Reviewed and fact-checked on May 20, 2026.